FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 52 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,017,000 | -72.6% | 809,854 | -14.6% | 0.06% | -68.1% |
| Q1 2022 | $7,369,000 | +86.3% | 948,327 | 0.0% | 0.18% | +103.3% |
| Q4 2021 | $3,955,000 | -47.3% | 948,327 | 0.0% | 0.09% | -42.4% |
| Q3 2021 | $7,511,000 | -2.0% | 948,327 | 0.0% | 0.16% | +4.6% |
| Q2 2021 | $7,662,000 | -24.6% | 948,327 | 0.0% | 0.15% | -32.0% |
| Q1 2021 | $10,166,000 | -8.8% | 948,327 | 0.0% | 0.22% | -5.9% |
| Q4 2020 | $11,143,000 | -2.2% | 948,327 | +0.1% | 0.24% | -18.3% |
| Q3 2020 | $11,389,000 | -30.4% | 947,541 | +1.1% | 0.29% | -35.6% |
| Q2 2020 | $16,370,000 | – | 937,041 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 2,973,744 | $24,028,000 | 4.99% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12,613,000 | 4.97% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29,658,000 | 3.03% |
| Sio Capital Management, LLC | 266,107 | $2,150,000 | 0.53% |
| Orbimed Advisors | 3,224,770 | $26,056,000 | 0.26% |
| Perceptive Advisors | 3,550,334 | $28,686,000 | 0.19% |
| AlphaCentric Advisors LLC | 71,500 | $578,000 | 0.16% |
| Rock Springs Capital Management LP | 948,327 | $7,662,000 | 0.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,618,000 | 0.15% |
| Artal Group S.A. | 750,000 | $6,060,000 | 0.12% |